Very true, and a measured position. PXS is in a good position though with a strong portfolio to develop and licence. Bronchitol could be a decent money spinner if/when rolled out in the US market. Surprised by the 2017 date for phase 2 (maybe they want to do a phase 1b next year before a phase 2) but in any case it's almost guaranteed that it will proceed and lead to at least another $40 million injection within 24 months, further swelling PXS's war chest.
Still think this one is undervalued - needs a roadshow to US and European investors, stale bulls (some of whom have posted their antipathy on HC) and large holder exiting are putting an artificial drag on the SP, look at some other pie in the sky biotech companies trading at $100 million plus with only a few quarters cash burn in the bank. PXS is near cash value, has a product with sales occurring and (hopefully) soon to grow and a host of other molecules, including one that is possibly very near to another exclusive deal... Definitely one to watch medium term.
- Forums
- ASX - By Stock
- SNT
- Well controlled Accumulations!!!! Beware everyone.
Well controlled Accumulations!!!! Beware everyone., page-8
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.0¢ |
Change
0.007(16.3%) |
Mkt cap ! $61.79M |
Open | High | Low | Value | Volume |
4.2¢ | 5.2¢ | 4.2¢ | $239.3K | 5.184M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 143497 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 154486 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 148940 | 0.050 |
1 | 638460 | 0.049 |
1 | 50000 | 0.047 |
1 | 80000 | 0.046 |
3 | 698333 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 640 | 1 |
0.052 | 346225 | 3 |
0.054 | 100000 | 1 |
0.055 | 25000 | 2 |
0.056 | 178571 | 1 |
Last trade - 14.56pm 17/10/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online